Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood substitutes.

Robert M Winslow1

  • 1Sangart, Inc., San Diego, California 92121, USA. rwinslow@sangart.com

Current Opinion in Hematology
|February 15, 2002
PubMed
Summary
This summary is machine-generated.

Blood substitutes, such as hemoglobin-based oxygen carriers, are advancing to address banked blood shortages and transfusion risks. Research is revealing new insights into tissue oxygenation and microcirculation regulation by these cell-free oxygen carriers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood Substitutes.

Surgical technology international·2017
Same author

Ventilation and the control of erythropoiesis in high-altitude natives of Chile and Nepal.

American journal of human biology : the official journal of the Human Biology Council·2017
Same author

Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia.

Artificial cells, nanomedicine, and biotechnology·2014
Same author

Oxygen: the poison is in the dose.

Transfusion·2012
Same author

Hemospan: design principles for a new class of oxygen therapeutic.

Artificial organs·2009
Same author

Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch.

Journal of cardiothoracic and vascular anesthesia·2008
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Critical Care Medicine

Background:

  • Banked blood shortages and transfusion risks necessitate alternatives to red blood cell transfusions.
  • Cell-free oxygen carriers, including hemoglobin-based products and perfluorocarbon emulsions, are in late-stage clinical development.
  • Existing blood transfusion methods carry inherent risks, driving the need for safer alternatives.

Purpose of the Study:

  • To review the development and function of cell-free oxygen carriers as blood substitutes.
  • To explore the impact of these novel oxygen carriers on tissue oxygenation and microcirculation.
  • To compare the performance of oxygen carriers with traditional volume expanders.

Main Methods:

  • Review of animal and human studies on hemoglobin-based oxygen carriers and perfluorocarbon emulsions.

Related Experiment Videos

  • Analysis of physiological concepts related to oxygen delivery and microvascular regulation.
  • Comparative assessment of oxygen carriers versus starch-based plasma expanders.

    • Main Results:

    • Cell-free oxygen carriers are progressing through clinical development, offering potential solutions to blood shortages.
    • Studies have elucidated novel mechanisms of tissue oxygen delivery and microcirculation regulation by these agents.
    • Comparisons with traditional products offer insights into oxygen transport, perfusion, and volume expansion.

    Conclusions:

    • Cell-free oxygen carriers represent a promising advancement in transfusion medicine.
    • Understanding their physiological effects is crucial for safe and effective clinical translation.
    • These products offer new perspectives on the interplay between oxygen transport, microcirculation, and hemodynamics.